| 29-07-2010 | Aptuit and Siena Biotech Announce Strategic Relationship in Italy
New models of R&D help to advance compounds in key disease areas |
|
|
| 13-07-2010 | Siena Biotech renewed the Scientific Advisory Board.
Members of Siena Biotech Ethics Committee were confirmed. |
|
|
| 12-06-2010 | Monte dei Paschi di Siena Foundation celebrates the Italian Foundations of Banking Origins Day opening Siena Biotech MRC to public. |
|
|
| 08-06-2010 | Giovanni Gaviraghi, Siena Biotech CEO, interviewed on "La Nazione" |
|
|
| 14-05-2010 | Giovanni Gaviraghi is confirmed Siena Biotech CEO |
|
|
| 07-05-2010 | Siena Biotech Board of Directors is renewed |
|
|
| 22-04-2010 | A ceremony was held for the presentation of the book: "Siena Biotech, l'edificio delle idee" |
|
|
| 08-04-2010 | Exploring the Davids and Goliaths of therapeutic molecules: A*STAR inks deals with Siena Biotech to develop small- and large-molecule therapies for cancer and bone loss diseases |
|
|
| 31-03-2010 | Roche exercises option on compounds from collaboration with Siena Biotech |
|
|
| 08-01-2010 | Siena Biotech Announces FDA and EMEA Orphan Drug Designations and Phase I Clinical Study of SEN0014196 for the Treatment of Huntington's Disease |
|
|
